CDI(CODX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results SALT LAKE CITY, November 7, 2024— Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Results: ● Revenue of $0.6 million, which declined from $2.5 million during the prior year primarily due to timing of grant revenue recogniti ...